Frisch Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Sell
7,546
-153
-2% -$33.9K 0.34% 43
2025
Q4
$1.76M Buy
7,699
+8
+0.1% +$1.82K 0.39% 40
2025
Q3
$1.78M Buy
7,691
+18
+0.2% +$3.67K 0.41% 38
2025
Q2
$1.42M Buy
7,673
+32
+0.4% +$5.95K 0.35% 45
2025
Q1
$1.6M Sell
7,641
-282
-4% -$54.8K 0.45% 36
2024
Q4
$1.41M Buy
7,923
+193
+2% +$35.5K 0.43% 38
2024
Q3
$1.53M Buy
7,730
+810
+12% +$151K 0.46% 35
2024
Q2
$1.19M Buy
6,920
+53
+0.8% +$8.78K 0.36% 40
2024
Q1
$1.25M Sell
6,867
-108
-2% -$18.6K 0.42% 33
2023
Q4
$1.08M Buy
6,975
+36
+0.5% +$5.25K 0.41% 36
2023
Q3
$1.03M Sell
6,939
-140
-2% -$20.6K 0.42% 39
2023
Q2
$954K Sell
7,079
-305
-4% -$44.7K 0.46% 41
2023
Q1
$1.18M Buy
7,384
+65
+0.9% +$9.94K 0.46% 42
2022
Q4
$1.18M Buy
7,319
+1
+0% +$153 0.44% 44
2022
Q3
$982K Buy
7,318
+234
+3% +$33.6K 0.42% 41
2022
Q2
$1.08M Buy
7,084
+60
+0.9% +$9.17K 0.42% 41
2022
Q1
$1.14M Sell
7,024
-1,226
-15% -$178K 0.37% 47
2021
Q4
$1.11M Sell
8,250
-184
-2% -$21.7K 0.35% 49
2021
Q3
$910K Buy
8,434
+61
+0.7% +$6.97K 0.3% 49
2021
Q2
$943K Buy
8,373
+165
+2% +$18.6K 0.3% 52
2021
Q1
$888K Buy
8,208
+145
+2% +$15.5K 0.3% 51
2020
Q4
$864K Buy
8,063
+322
+4% +$30.9K 0.32% 40
2020
Q3
$678K Buy
7,741
+91
+1% +$8.57K 0.3% 44
2020
Q2
$751K Sell
7,650
-8,124
-52% -$715K 0.35% 38
2020
Q1
$1.2M Buy
15,774
+5,919
+60% +$504K 0.7% 30
2019
Q4
$873K Buy
9,855
+6,013
+157% +$499K 0.41% 42
2019
Q3
$291K Buy
+3,842
New +$263K 0.18% 76
2019
Q1
Sell
-2,409
Closed -$222K 105
2018
Q4
$222K Buy
+2,409
New +$212K 0.16% 87

Other funds holding ABBV